GP

Guntupalli Pratyusha

Active Director Director DIN 06390402
DIN 06390402 First appointment Sep 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Sep 2012
Shareholding value •••• Premium profile

About Guntupalli Pratyusha

Data last updated:

Guntupalli Pratyusha is a Director at Chemveda Life Sciences India Private Limited (since 2016) and Whole-Time Director at Mahalakshmi Laboratories Private Limited (since 2022). The companies operate in Pharma, Agriculture and Chemicals and Materials. The 2 current companies with reported revenue have a combined latest revenue of ₹149 Cr; the largest is Chemveda Life Sciences India Private Limited at ₹116 Cr (FY 2024). Earlier, Guntupalli Pratyusha was a Director at Aegis Agro Chemicals (India) Private Limited (2012–2024) and Designated Partner at Legend Agro Chemicals Llp (2015–2017) and 1 more.

DIN 06390402
Primary Designation Director
Industry Pharma
First Appointment 23 Sep 2012
Oldest Company Age 20 yrs
Largest company Chemveda Life Sciences India Private Limited · ₹116 Cr (FY 2024)
Combined revenue ₹149 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Apr 20162008₹116 Cr (FY 2024)Active
Whole-Time Director06 Apr 20222006₹33.56 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Sep 20122012₹174 Cr (FY 2025)Active
Designated Partner22 May 20152015Active
Gps Biotech Private Limited U24301TG2013PTC091978
Director27 Dec 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chemveda Life Sciences India Private Limited
Gps Biotech Private Limited
Mahalakshmi Laboratories Private Limited
Aegis Agro Chemicals (India) Private Limited
Premium access

Shareholding and investment profile for Guntupalli Pratyusha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Guntupalli Pratyusha

Guntupalli Pratyusha currently holds 2 directorships: Chemveda Life Sciences India Private Limited (Director, since 14 Apr 2016, revenue ₹116 Cr (FY 2024)); Mahalakshmi Laboratories Private Limited (Whole-Time Director, since 06 Apr 2022, revenue ₹33.56 Cr (FY 2025)).

Guntupalli Pratyusha was first appointed on 23 Sep 2012 as Director at Aegis Agro Chemicals (India) Private Limited. The most recent appointment on record is 06 Apr 2022 at Mahalakshmi Laboratories Private Limited.

The 2 current companies of Guntupalli Pratyusha that report revenue have a combined latest revenue of ₹149 Cr: Chemveda Life Sciences India Private Limited ₹116 Cr (FY 2024); Mahalakshmi Laboratories Private Limited ₹33.56 Cr (FY 2025).

Guntupalli Pratyusha held 3 earlier board appointments: Aegis Agro Chemicals (India) Private Limited (Director, 23 Sep 2012 to 05 Sep 2024); Legend Agro Chemicals Llp (Designated Partner, 22 May 2015 to 01 Apr 2017); Gps Biotech Private Limited (Director, from 27 Dec 2013).

The current boards of Guntupalli Pratyusha's companies include Hithaishi Paraselli (Chemveda Life Sciences India Private Limited), Nidhi Khandelwal (Chemveda Life Sciences India Private Limited), Paraselli Bheemarao (Chemveda Life Sciences India Private Limited), Veera Venkata Rama Rao Remella (Chemveda Life Sciences India Private Limited), Jagannadham Bevara (Mahalakshmi Laboratories Private Limited), Padmaja Rani Velecheti (Mahalakshmi Laboratories Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available